Michael Kirschfink

Institute of Immunology

0H指数

0论文数

0被引数

收录论文 98

发表时间

Correction to: Chemotherapy of breast cancer cells alters susceptibility to complement‑mediated opsonization and killing 更正：乳腺癌细胞化疗改变了对补体介导的调理作用和杀灭作用的易感性

Medical Oncology

IF3.5

2026-03-24

PREAI

Mohamed Hassan Nasraa; Mahmoud Mohamed Bahgat; Michael Kirschfinik

External quality assurance program for diagnostic complement laboratories: evaluation of the results of the past seven years 诊断补充实验室的外部质量保证计划: 对过去七年结果的评估

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-03-26

OAAI

Kirschfink, Michael; Frazer-Abel, Ashley; Balogh, Emese; Goseberg, Sabine; Weiss, Nathalie; Prohaszka, Zoltan

Editorial: Contemporary challenges in immunologic testing in clinical and research laboratories

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-07-27

OAAI

Andrade, Luis Eduardo C.; Chan, Edward K. L.; Vieths, Stefan; Engel, Pablo; Kirschfink, Michael

Expanding Horizons in Complement Analysis and Quality Control 扩大补充分析和质量控制的视野

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-08-09

OAAI

Frazer-Abel, Ashley; Kirschfink, Michael; Prohaszka, Zoltan

Janus kinase inhibition in complement component 1 deficiency

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2020-12-01

OAAI

Wolf, Christine; Bruck, Normi; Koss, Sarah; Griep, Constanze; Kirschfink, Michael; Palm-Beden, Katharina; Fang, Mingyan; Roeber, Nadja; Winkler, Stefan; Berner, Reinhard; Latz, Eike; Guenther, Claudia; Lee-Kirsch, Min Ae

Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management 补体缺陷和失调: 病理生理后果，现代分析和临床管理

MOLECULAR IMMUNOLOGY

IF3

2019-10-01

PREAI

Schroeder-Braunstein, Jutta; Kirschfink, Michael

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3-and C5-Convertases C3-Glomerulopathy自身抗体介导对补体C3-and C5-Convertases的不同作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-05-31

OAAI

Zhao, Fei; Afonso, Sara; Lindner, Susanne; Hartmann, Andrea; Loeschmann, Ina; Nilsson, Bo; Ekdahl, Kristina N.; Weber, Lutz T.; Habbig, Sandra; Schalk, Gesa; Kirschfink, Michael; Zipfel, Peter F.; Skerka, Christine

Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-04-10

OAAI

Fishelson, Zvi; Kirschfink, Michael

Controlling complement 5a (C5a) in disease setting requires a specifically targeted inhibition 在疾病环境中控制补体5a (C5a) 需要特异性靶向抑制

MOLECULAR IMMUNOLOGY

IF3

2018-10-01

PREAI

Guo, Renfeng; Habel, Maria; Ziereisen, Jana; Hermann, Marlen; Xu, Zhongli; Zenker, Othmar; Kirschfink, Michael; Riedemann, Niels

Complement analysis in the era of targeted therapeutics 靶向治疗时代的补体分析

MOLECULAR IMMUNOLOGY

IF3

2018-10-01

OAAI

Prohaszka, Zoltan; Kirschfink, Michael; Frazer-Abel, Ashley

Long-term Eculizumab Therapy in a Child With Refractory Immune Complex-Mediated Membranoproliferative Glomerulonephritis

KIDNEY INTERNATIONAL REPORTS

IF5.7

2018-03-01

OAAI

Chanchlani, Rahul; Thorner, Paul; Radhakrishnan, Seetha; Hebert, Diane; Langlois, Valerie; Arora, Steven; Barth, David; Cattran, Daniel; Kirschfink, Michael; Licht, Christoph

Local complement activation in aqueous humor in patients with age-related macular degeneration

MOLECULAR IMMUNOLOGY

IF3

2017-09-01

OAAI

Kirschfink, Michael; Schick, Tina; Steinhauer, Marlin; Aslanidis, Alexander; Altay, Lebriz; Karlstetter, Marcus; Langmann, Thomas; Fauser, Sascha

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

CLINICAL KIDNEY JOURNAL

IF4.6

2017-07-10

OAAI

Muench, Johannes; Bachmann, Anette; Grohmann, Maik; Mayer, Christof; Kirschfink, Michael; Lindner, Tom H.; Bergmann, Carsten; Halbritter, Jan

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2016-11-25

OAAI

Wehling, C.; Amon, O.; Bommer, M.; Hoppe, B.; Kentouche, K.; Schalk, G.; Weimer, R.; Wiesener, M.; Hohenstein, B.; Toenshoff, B.; Buescher, R.; Fehrenbach, H.; Goek, Oe. -N.; Kirschfink, M.

A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL

JOURNAL OF HYPERTENSION

IF4.1

2016-09-01

PREAI

Mitchell, A.; Nokay, B.; Guberina, H.; Behlen-Wilm, U.; Nagel, M.; Kirschfink, M.; Wiech, T.; Kribben, A.; Bienholz, A.

Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors 来自健康供体外周血的IgM抗体介导的对人神经母细胞瘤和黑色素瘤细胞的细胞毒活性

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2016-02-23